A detailed history of Ballentine Partners, LLC transactions in Cvs Health Corp stock. As of the latest transaction made, Ballentine Partners, LLC holds 4,521 shares of CVS stock, worth $200,054. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,521
Previous 12,459 63.71%
Holding current value
$200,054
Previous $735,000 61.36%
% of portfolio
0.0%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$55.81 - $63.18 $443,019 - $501,522
-7,938 Reduced 63.71%
4,521 $284,000
Q2 2024

Aug 06, 2024

BUY
$53.63 - $79.56 $227,283 - $337,175
4,238 Added 51.55%
12,459 $735,000
Q1 2024

Apr 11, 2024

SELL
$71.99 - $81.42 $204,091 - $230,825
-2,835 Reduced 25.64%
8,221 $655,000
Q4 2023

Jan 23, 2024

SELL
$66.29 - $79.0 $281,666 - $335,671
-4,249 Reduced 27.76%
11,056 $872,000
Q3 2023

Oct 19, 2023

BUY
$65.17 - $76.41 $438,789 - $514,468
6,733 Added 78.55%
15,305 $1.07 Million
Q2 2023

Jul 26, 2023

SELL
$66.65 - $77.75 $181,821 - $212,102
-2,728 Reduced 24.14%
8,572 $592,000
Q1 2023

Apr 27, 2023

SELL
$72.37 - $92.89 $126,068 - $161,814
-1,742 Reduced 13.36%
11,300 $839,000
Q4 2022

Jan 27, 2023

BUY
$88.25 - $103.78 $132,463 - $155,773
1,501 Added 13.01%
13,042 $0
Q3 2022

Oct 26, 2022

BUY
$92.53 - $106.43 $248,165 - $285,445
2,682 Added 30.27%
11,541 $1.1 Million
Q2 2022

Aug 09, 2022

SELL
$88.66 - $106.64 $14,628 - $17,595
-165 Reduced 1.83%
8,859 $821,000
Q1 2022

May 05, 2022

BUY
$100.77 - $110.83 $79,910 - $87,888
793 Added 9.63%
9,024 $913,000
Q4 2021

Feb 14, 2022

SELL
$83.15 - $103.7 $16,131 - $20,117
-194 Reduced 2.3%
8,231 $849,000
Q3 2021

Oct 27, 2021

BUY
$80.05 - $87.47 $1,601 - $1,749
20 Added 0.24%
8,425 $715,000
Q2 2021

Aug 12, 2021

SELL
$73.79 - $89.81 $49,144 - $59,813
-666 Reduced 7.34%
8,405 $702,000
Q1 2021

May 11, 2021

BUY
$68.13 - $76.3 $42,581 - $47,687
625 Added 7.4%
9,071 $682,000
Q4 2020

Jan 25, 2021

SELL
$55.93 - $74.5 $75,393 - $100,426
-1,348 Reduced 13.76%
8,446 $577,000
Q3 2020

Oct 22, 2020

SELL
$56.71 - $65.71 $170,300 - $197,327
-3,003 Reduced 23.47%
9,794 $572,000
Q2 2020

Jul 31, 2020

SELL
$55.41 - $70.62 $125,004 - $159,318
-2,256 Reduced 14.99%
12,797 $831,000
Q1 2020

Apr 23, 2020

BUY
$52.3 - $76.05 $293,769 - $427,172
5,617 Added 59.53%
15,053 $893,000
Q4 2019

Jan 22, 2020

SELL
$60.38 - $76.58 $20,106 - $25,501
-333 Reduced 3.41%
9,436 $700,000
Q3 2019

Oct 21, 2019

BUY
$54.09 - $64.3 $122,135 - $145,189
2,258 Added 30.06%
9,769 $616,000
Q2 2019

Jul 25, 2019

BUY
$52.13 - $57.33 $149,925 - $164,881
2,876 Added 62.05%
7,511 $409,000
Q1 2019

May 09, 2019

SELL
$52.36 - $69.88 $223,734 - $298,597
-4,273 Reduced 47.97%
4,635 $250,000
Q4 2018

Feb 04, 2019

BUY
$62.92 - $80.8 $129,992 - $166,932
2,066 Added 30.2%
8,908 $584,000
Q3 2018

Oct 30, 2018

BUY
$63.78 - $79.59 $28,254 - $35,258
443 Added 6.92%
6,842 $539,000
Q2 2018

Jul 19, 2018

BUY
$60.71 - $72.18 $28,715 - $34,141
473 Added 7.98%
6,399 $412,000
Q1 2018

Apr 26, 2018

SELL
$60.6 - $83.63 $198,586 - $274,055
-3,277 Reduced 35.61%
5,926 $369,000
Q4 2017

Feb 02, 2018

BUY
$66.8 - $80.91 $27,254 - $33,011
408 Added 4.64%
9,203 $667,000
Q3 2017

Nov 06, 2017

BUY
$75.35 - $83.31 $662,703 - $732,711
8,795
8,795 $716,000

Others Institutions Holding CVS

About CVS HEALTH Corp


  • Ticker CVS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 1,312,829,952
  • Market Cap $58.1B
  • Description
  • CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governme...
More about CVS
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.